Appendix F
Pre survey announcement, surveys 2, and 3:
Dear Sir/Madam:
The Clinical and Laboratory Standards Institute (CLSI), in collaboration with the Centers for Disease Control and Prevention (CDC), is conducting a study to improve the usefulness of laboratory practice guidelines (LPGs) that address fingerstick glucose testing procedures. As a facility that may potentially perform point-of-care fingerstick glucose testing, you have been selected to receive this survey. This survey should be completed by the individual at your site who is responsible for developing your fingerstick glucose testing procedures.
A link to the survey will be distributed by e-mail within the next 4 –6 weeks. Participation in this study is voluntary and responses will be anonymous. CLSI will collect and analyze the data and share with CDC. By responding to this survey, you can provide information that will help CLSI improve the usefulness of its laboratory practice guidelines that address fingerstick glucose testing procedures; with an overall goal to improve the quality of care provided to all patients in any health care setting.
Thank you for your help with this important study.
Regards,
D avid E. Sterry, MT (ASCP)
Director, Standards
Secretary, ISO/TC 212
Clinical and Laboratory Standards Institute
950 West Valley Road, Suite 2500
Wayne, PA 19087 USA www.clsi.org
Direct Line: 484.588.5942
Fax: 610.688.0700
The mark ‘CDC’ is
owned by the US Dept. of Health and Human Services and is used with
permission. Use of this logo is not an endorsement by HHS or CDC of
any particular product, service, or enterprise.
First Survey announcement, surveys 2, and 3:
Dear Sir/Madam:
Thank you for taking the time to complete this survey developed by the Clinical and Laboratory Standards Institute (CLSI) in collaboration with the Centers for Disease Control and Prevention (CDC). Your feedback is important for guiding CLSI and CDC in their efforts to improve the usefulness of laboratory practice guidelines; with an overall goal to improve the quality of care provided to all patients in any health care setting.
This survey should be completed by the individual at your site who is responsible for developing your fingerstick glucose testing procedures. The survey should take approximately 15 minutes to complete. Participation in this study is voluntary and responses will be anonymous. CLSI will collect and analyze the data and share with CDC.
Please use the following link to access the survey: SURVEY_URL. The survey will be available until month/date/year.
Please contact Mr. David Sterry (dsterry@clsi.org) if you have any questions about the survey or who should complete the survey.
Thank you for your help with this important study.
Regards,
D avid E. Sterry, MT (ASCP)
Director, Standards
Secretary, ISO/TC 212
Clinical and Laboratory Standards Institute
950 West Valley Road, Suite 2500
Wayne, PA 19087 USA www.clsi.org
Direct Line: 484.588.5942
The mark ‘CDC’ is
owned by the US Dept. of Health and Human Services and is used with
permission. Use of this logo is not an endorsement by HHS or CDC of
any particular product, service, or enterprise.
Email: dsterry@clsi.org
Reminder email, surveys 2, and 3:
Dear Sir/Madam:
If you have not yet completed the Clinical and Laboratory Standards Institute (CLSI)/Centers for Disease Control and Prevention (CDC) survey, this e-mail serves as a reminder for you to complete the survey at the following link: SURVEY_URL. The survey will be available until month/date/year.
Thank you for taking the time to complete this survey by CLSI in collaboration with CDC. Your feedback is important for guiding CLSI and CDC in their efforts to improve the usefulness of laboratory practice guidelines; with an overall goal to improve the quality of care provided to all patients in any health care setting. This survey should be completed by the individual at your site who is responsible for developing your fingerstick glucose testing procedures. The survey should take approximately 15 minutes to complete. Participation in this study is voluntary and responses will be anonymous. CLSI will collect and analyze the data and share with CDC.
Please contact Mr. David Sterry (dsterry@clsi.org) if you have any questions about the survey or who should complete the survey.
Thank you for your help with this important study.
R egards,
David E. Sterry, MT (ASCP)
Director, Standards
Secretary, ISO/TC 212
Clinical and Laboratory Standards Institute
950 West Valley Road, Suite 2500
The mark ‘CDC’ is
owned by the US Dept. of Health and Human Services and is used with
permission. Use of this logo is not an endorsement by HHS or CDC of
any particular product, service, or enterprise.
Direct Line: 484.588.5942
Fax: 610.688.0700
Email: dsterry@clsi.org
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Lisa Kalman |
File Modified | 0000-00-00 |
File Created | 2021-01-24 |